Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease - PubMed (original) (raw)
Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease
N R Sims et al. Lancet. 1980.
Abstract
The metabolism of (U--14C) glucose and its incorporation into acetylcholine were determined in vitro in fresh cortical biopsy samples from patients with Alzheimer's disease and controls. Synthesis of 14C acetylcholine was significantly reduced (60% and 67% reduction under stimulated and resting conditions, respectively) without significant changes in the overall metabolism of glucose (as measured by 14CO2 production). Acetylcholine synthesis was directly related to the activity of choline acetyltransferase. The changes in cholinergic markers reflected the severity of psychological defects. Acetylcholine synthesis was not reduced in biopsy samples from patients suffering from presenile dementia with no histological evidence of Alzheimer's disease.
Similar articles
- Presynaptic cholinergic dysfunction in patients with dementia.
Sims NR, Bowen DM, Allen SJ, Smith CC, Neary D, Thomas DJ, Davison AN. Sims NR, et al. J Neurochem. 1983 Feb;40(2):503-9. doi: 10.1111/j.1471-4159.1983.tb11311.x. J Neurochem. 1983. PMID: 6822833 - [14C]acetylcholine synthesis and [14C]carbon dioxide production from [U-14C]glucose by tissue prisms from human neocortex.
Sims NR, Bowen DM, Davison AN. Sims NR, et al. Biochem J. 1981 Jun 15;196(3):867-76. doi: 10.1042/bj1960867. Biochem J. 1981. PMID: 6797411 Free PMC article. - Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.
Wilcock GK, Esiri MM, Bowen DM, Smith CC. Wilcock GK, et al. J Neurol Sci. 1982 Dec;57(2-3):407-17. doi: 10.1016/0022-510x(82)90045-4. J Neurol Sci. 1982. PMID: 7161627 - The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease.
Mesulam MM. Mesulam MM. Prog Brain Res. 1996;109:285-97. doi: 10.1016/s0079-6123(08)62112-3. Prog Brain Res. 1996. PMID: 9009717 Review. No abstract available. - Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?
Palmer AM, Gershon S. Palmer AM, et al. FASEB J. 1990 Jul;4(10):2745-52. doi: 10.1096/fasebj.4.10.2165009. FASEB J. 1990. PMID: 2165009 Review.
Cited by
- Physostigmine for Alzheimer's disease.
Coelho F, Birks J. Coelho F, et al. Cochrane Database Syst Rev. 2001;2001(2):CD001499. doi: 10.1002/14651858.CD001499. Cochrane Database Syst Rev. 2001. PMID: 11405996 Free PMC article. Review. - Pathogenesis of Alzheimer's disease--beyond the cholinergic hypothesis: discussion paper.
Harrison PJ. Harrison PJ. J R Soc Med. 1986 Jun;79(6):347-52. doi: 10.1177/014107688607900612. J R Soc Med. 1986. PMID: 2873250 Free PMC article. Review. No abstract available. - Alzheimer's disease is type 3 diabetes-evidence reviewed.
de la Monte SM, Wands JR. de la Monte SM, et al. J Diabetes Sci Technol. 2008 Nov;2(6):1101-13. doi: 10.1177/193229680800200619. J Diabetes Sci Technol. 2008. PMID: 19885299 Free PMC article. - Diabetes Mellitus-Related Fractional Glucose Uptake in Men and Women Imaged With 18F-FDG PET-CT.
Waqas K, van Haard PMM, Postema JWA, Schweitzer DH. Waqas K, et al. J Endocr Soc. 2019 Feb 27;3(4):773-783. doi: 10.1210/js.2019-00001. eCollection 2019 Apr 1. J Endocr Soc. 2019. PMID: 30963135 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical